CYC.AX
Price:
$1.995
Market Cap:
$221.72M
Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. It operates through Technegas and Molecular Imaging segments. The Technegas segment offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. This segment also distributes third party products to the diagnostic imaging sector. The Molecular Imaging segment provides radiopharmaceuticals that are used by physicians in the detection of cancer, neurological disorders, and cardiac diseases. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is headquartered in Kingsgrove, ...[Read more]
Industry
Medical - Devices
IPO Date
2007-01-17
Stock Exchange
ASX
Ticker
CYC.AX
According to Cyclopharm Limited’s latest financial reports and current stock price. The company's current PE Ratio is -19.95. This represents a change of 51.24% compared to the average of -13.19 of the last 4 quarters.
The mean historical PE Ratio of Cyclopharm Limited over the last ten years is -224.84. The current -19.95 PE Ratio has changed 787.31% with respect to the historical average. Over the past ten years (40 quarters), CYC.AX's PE Ratio was at its highest in in the December 2019 quarter at 205.95. The PE Ratio was at its lowest in in the December 2017 quarter at -194.25.
Average
-224.84
Median
-28.37
Minimum
-2128.02
Maximum
56.94
Discovering the peaks and valleys of Cyclopharm Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 4.68%
Maximum Annual PE Ratio = 56.94
Minimum Annual Increase = -178.21%
Minimum Annual PE Ratio = -2128.02
Year | PE Ratio | Change |
---|---|---|
2023 | -38.04 | 133.23% |
2022 | -16.31 | -44.03% |
2021 | -29.15 | -8.01% |
2020 | -31.68 | 14.79% |
2019 | -27.60 | -98.70% |
2018 | -2128.02 | 4.68% |
2017 | -44.53 | -178.21% |
2016 | 56.94 | 842.24% |
2015 | 6.04 | 51.68% |
2014 | 3.98 | -121.57% |
The current PE Ratio of Cyclopharm Limited (CYC.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-27.83
5-year avg
-28.56
10-year avg
-224.84
Cyclopharm Limited’s PE Ratio is greater than Compumedics Limited (-94.08), less than Cogstate Limited (22.65), less than ImpediMed Limited (-5.48), less than LBT Innovations Limited (-7.06), less than SomnoMed Limited (-4.39),
Company | PE Ratio | Market cap |
---|---|---|
-94.08 | $48.70M | |
22.65 | $186.22M | |
-5.48 | $107.29M | |
-7.06 | $29.89M | |
-4.39 | $96.17M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cyclopharm Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cyclopharm Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Cyclopharm Limited's PE Ratio?
How is the PE Ratio calculated for Cyclopharm Limited (CYC.AX)?
What is the highest PE Ratio for Cyclopharm Limited (CYC.AX)?
What is the 3-year average PE Ratio for Cyclopharm Limited (CYC.AX)?
What is the 5-year average PE Ratio for Cyclopharm Limited (CYC.AX)?
How does the current PE Ratio for Cyclopharm Limited (CYC.AX) compare to its historical average?